UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
Clinical trial NCT03224871 · COMPLETED
Trial details
- NCT number
- NCT03224871
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-11
- Primary completion
- 2020-01-10
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.